Vestaron Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
51
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$103M
- Investors
-
20
Vestaron General Information
Description
Developer of peptide-based insecticides designed for sustainable crop protection. The company has developed a platform that uses naturally occurring peptides with novel modes of action, short re-entry and preharvest intervals, no residue restrictions, and low impact on pollinators and beneficials, enabling growers to protect yields, manage resistance, and reduce reliance on synthetic pesticides.
Contact Information
Website
www.vestaron.comCorporate Office
- 4025 Stirrup Creek Drive
- Suite 400
- Durham, NC 27703
- United States
Corporate Office
- 4025 Stirrup Creek Drive
- Suite 400
- Durham, NC 27703
- United States
Vestaron Timeline
Vestaron Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 03-Apr-2025 | $103M | Completed | Generating Revenue | ||
| 13. Later Stage VC | 24-Jan-2025 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series C) | 15-Aug-2022 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Private | 01-Jun-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B1) | 10-Feb-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 04-Jun-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series D) | 22-Jul-2016 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 19-Aug-2014 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jan-2013 | $100K | $14.4M | Completed | Generating Revenue | |
| 5. Later Stage VC (Series B) | 08-May-2012 | $10.2M | $14.4M | Completed | Generating Revenue |
Vestaron Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C Prime | ||||||||
| Series B-1 Prime | ||||||||
| Series B Prime | ||||||||
| Series A Prime | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | 36,249,058 | $0.001000 | $1.82 | $1.82 | 1x | $1.82 | 31.01% | |
| Series A | 7,581,596 | $0.001000 | $1.82 | $1.82 | 1x | $1.82 | 6.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Vestaron Comparisons
Industry
Financing
Details
Vestaron Competitors (19)
One of Vestaron’s 19 competitors is Ostara, a Private Equity-Backed company based in Saint Louis, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ostara | Private Equity-Backed | Saint Louis, MO | ||||
| AgroFresh | Private Equity-Backed | Philadelphia, PA | ||||
| AgBiTech | Formerly PE-Backed | Fort Worth, TX | ||||
| Enko | Venture Capital-Backed | Mystic, CT | ||||
| Sound Agriculture | Venture Capital-Backed | Emeryville, CA |
Vestaron Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vestaron Patents
Vestaron Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026198282-A1 | Hexatoxin variant peptides | Pending | 21-Mar-2025 | ||
| WO-2025226701-A1 | Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control | Pending | 23-Apr-2024 | ||
| AU-2024321251-A1 | Delta-amaurobitoxin pl1c variant polypeptides for pest control | Pending | 04-Aug-2023 | ||
| WO-2025034576-A1 | Delta-amaurobitoxin pl1c variant polypeptides for pest control | Inactive | 04-Aug-2023 | ||
| EP-4754116-A1 | Omega hexatoxin variant peptides and methods of use thereof | Pending | 31-Jul-2023 | C07K14/43518 |
Vestaron Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vestaron Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Argonautic Ventures | Venture Capital | Minority | ||
| Endeavor8 | Venture Capital | Minority | ||
| Fortistar | Growth/Expansion | Minority | ||
| Grosvenor Food & AgTech | Impact Investing | Minority | ||
| Angel (individual) | Minority |
Vestaron FAQs
-
When was Vestaron founded?
Vestaron was founded in 2005.
-
Where is Vestaron headquartered?
Vestaron is headquartered in Durham, NC.
-
What is the size of Vestaron?
Vestaron has 51 total employees.
-
What industry is Vestaron in?
Vestaron’s primary industry is Agricultural Chemicals.
-
Is Vestaron a private or public company?
Vestaron is a Private company.
-
What is the current valuation of Vestaron?
The current valuation of Vestaron is .
-
What is Vestaron’s current revenue?
The current revenue for Vestaron is .
-
How much funding has Vestaron raised over time?
Vestaron has raised $302M.
-
Who are Vestaron’s investors?
Argonautic Ventures, Endeavor8, Fortistar, Grosvenor Food & AgTech, and are 5 of 20 investors who have invested in Vestaron.
-
Who are Vestaron’s competitors?
Ostara, AgroFresh, AgBiTech, Enko, and Sound Agriculture are some of the 19 competitors of Vestaron.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
